ILMN
ILLUMINA, INC.
- PER (TTM)
- 25.80
- PER (Forward)
- 24.00
- EPS (TTM)
- -
- EPS (Forward)
- -
- PBR
- 8.11
- 시가총액
- 21.47B
- 배당수익률
- -
- 베타
- 1.42
- 1개월 수익률
- 14.72%
- 3개월 수익률
- 18.51%
- 6개월 수익률
- 15.88%
- 1년 수익률
- 85.83%
- 2년 수익률
- -
- 5일 평균거래량
- 1464320
- 60일 평균거래량
- 1697747
- 1년 평균거래량
- 1907562
- 5d/60d 거래량 비율
- 0.86×
- 60d/1y 거래량 비율
- 0.89×
- 변동성(60일, 연환산)
- 41.32%
- BB 스퀴즈 스코어
- 0.96
- SMA50 비율
- 1.11
- SMA200 비율
- 1.19
- RSI (14)
- 62
- 20일 수렴도
- 0.04
- 52주 최고
- 153.95
- 52주 최저
- 75.76
- 고점 대비
- -7.84%
- 저점 대비
- 87.28%
펀더멘털 갱신: 2026-05-10T09:32:03+00:00 · 시세 갱신: 2026-05-10T06:42:56+00:00
회사 정보
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.